藥學系

Pharmacology, Toxicology and Pharmaceutical Science

1. Cohort Study 100%
2. Cytotoxicity 84%
3. Malignant Neoplasm 55%
4. Carbazole Derivative 54%
5. Murraya 52%
6. Acridone Derivative 52%
7. Anti-Inflammatory Drug 46%
8. Aristolochia 37%
9. Superoxide 35%
10. Cerebrovascular Accident 34%
11. IC50 34%
12. Elastase 32%
13. sodium glucose cotransporter-2 inhibitors 32%
14. Brain Ischemia 30%
15. Non Insulin Dependent Diabetes Mellitus 29%
16. Coumarin Derivative 28%
17. Pummelo 27%
18. Antiplatelet 26%
19. Multidrug Resistance 24%
20. Rutaceae 22%
21. Antipsychotic 22%
22. Coumarin 21%
23. Glucagon Like Peptide 1 Receptor Agonist 20%
24. Denosumab 20%
25. Clausena 20%
26. Excavata 20%
27. Lead Compound 19%
28. Triterpenoid 19%
29. Hairless Mouse 19%
30. Structure Activity Relationship 19%
31. Reactive Oxygen Metabolite 18%
32. Hemodialysis 18%
33. Sesquiterpene 18%
34. Inflammation 17%
35. End Stage Renal Disease 17%
36. Chalcone 17%
37. Dimer 17%
38. Atrial Fibrillation 17%
39. Prevalence 16%
40. Flavonoid 16%
41. Biological Activity 16%
42. Methanol 16%
43. Minoxidil 15%
44. Adverse Drug Reaction 14%
45. Calcium Ion 14%
46. Tumor Necrosis Factor Inhibitor 14%
47. Diseases 14%
48. Adverse Event 14%
49. Neoplasm 14%
50. Antithrombocytic Agent 13%
51. Aromatic Compound 13%
52. Chronic Kidney Failure 13%
53. 4 Quinolone Derivative 13%
54. Chalcone Derivative 13%
55. Ficus 13%
56. Anticoagulant Agent 13%
57. Hypotension 13%
58. Statin (Protein) 13%
59. Brain Hemorrhage 13%
60. Observational Study 12%
61. Case-Control Study 12%
62. Congestive Heart Failure 12%
63. P-Glycoprotein 12%
64. Diabetes Mellitus 11%
65. Sodium Glucose Cotransporter 2 Inhibitor 11%
66. Acetone 11%
67. Antioxidant 11%
68. Arachidonic Acid 11%
69. Nanoparticle 11%
70. Glycoside 11%
71. Medication Error 11%
72. Leporidae 11%
73. Pedunculata 11%
74. Acetophenone Derivative 11%
75. Propylene Glycol 11%
76. Acute Heart Infarction 11%
77. Paclitaxel 11%
78. Comorbidity 10%
79. Flavonoid glycoside 10%
80. Antidepressant 10%
81. Hydroxyapatite 10%
82. Bipolar Disorder 10%
83. Hip Fracture 10%
84. High Performance Liquid Chromatography 10%
85. Cryptocarya 10%
86. Eurycoma 10%
87. Aristolochic Acid 10%
88. Citron 10%
89. Diterpenoid 10%
90. Antihypertensive 9%
91. Retrospective Study 9%
92. Escherichia coli 9%
93. Anticarcinogen 9%
94. Clinical Trial 9%
95. Ischemic Heart Disease 9%
96. Randomized Controlled Trial 9%
97. Aflibercept 9%
98. Mannich Base 9%
99. Ranibizumab 9%
100. Transient Ischemic Attack 9%

Keyphrases

1. Alkaloids 50%
2. Taiwan 46%
3. Carbazole Alkaloids 45%
4. Aristolochia 40%
5. Murraya 37%
6. Acridone Alkaloids 35%
7. Coumarin 35%
8. Root Bark 28%
9. Rutaceae 26%
10. Spectral Analysis 23%
11. Citrus Grandis 20%
12. Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i) 20%
13. Hayata 19%
14. Triterpenoids 17%
15. Glycosmis 17%
16. Antiplatelet Activity 17%
17. Sesquiterpenes 17%
18. Clausena Excavata 17%
19. Anti-inflammatory Activity 17%
20. Flavonoids 16%
21. Chemical Constituents 16%
22. Cytotoxicity 16%
23. Stem Bark 15%
24. Target Trial Emulation 15%
25. Hazard Ratio 15%
26. Spectral Method 15%
27. Spectroscopic Techniques 14%
28. Spectral Data 14%
29. Confidence Interval 14%
30. Benzenoid 13%
31. Focal Cerebral Ischemia 13%
32. Murraya Paniculata 13%
33. Chemical Transformation 13%
34. Stereochemistry 12%
35. Type 2 Diabetes Mellitus (T2DM) 12%
36. Type 2 Diabetic Patients 12%
37. Isolated Compounds 11%
38. Chronic Kidney Disease 11%
39. Receptor Agonist 11%
40. Multi-institutional 10%
41. Carbazole 10%
42. Acronychia Pedunculata 10%
43. Spectroscopic Analysis 10%
44. A1 Receptor 10%
45. Glucagon-like 10%
46. Retrospective Cohort Study 10%
47. Heterophylla 10%
48. Aristolochia Elegans 10%
49. Bichalcone 10%
50. Nothapodytes Foetida 10%
51. Corydalis 10%
52. Maytenus Emarginata 10%
53. Sesquiterpene Pyridine Alkaloids 10%
54. Cryptocarya chinensis 10%
55. Acetophenone 10%
56. Formosan 10%
57. Flueggea Virosa 10%
58. N-oxides 9%
59. Fruiting Body 8%
60. Scopoletin 8%
61. Phellamurin 8%
62. Single Crystal X-ray Analysis 8%
63. Diterpenoids 8%
64. 2D NMR 8%
65. Superoxide Production 8%
66. Elastase Release 8%
67. Glucoside 8%
68. Chemical Evidence 7%
69. Antiplatelet Agents 7%
70. Emulation Framework 7%
71. Acridone 7%
72. National Cohort Study 7%
73. Population-based Cohort Study 7%
74. Aristolochic Acid 7%
75. Tyrosinase Inhibition 7%
76. Glycosides 7%
77. Inhibitory Activity 7%
78. Aristolactam 7%
79. Nested Case-control Study 7%
80. Population-based Study 6%
81. Croton Tonkinensis 6%
82. Viscolin 6%
83. Carbon Linkages 6%
84. C20-diterpenoid Alkaloid 6%
85. 1D NMR 6%
86. Chemical Experiment 6%
87. Atrial Fibrillation 6%
88. Paeonia Suffruticosa 6%
89. Urinary Tract Infection 6%
90. 13C nuclear Magnetic Resonance 6%
91. Correlation Spectroscopy 6%
92. Flavones 6%
93. Coagulation Factor Replacement Therapy 6%
94. 2-phenyl-4-quinolone 6%
95. Self-controlled Case Series Study 6%
96. Rubia Yunnanensis 6%
97. Phalaenopsis 6%
98. NALM-6 6%
99. Rhinacanthin 6%
100. Naphthoquinone 6%